SEC Company Response from Cyclerion Therapeutics, Inc. (CYCN) (CIK 0001755237) (KRSA) — Apr 22, 2019
Cyclerion Therapeutics, Inc. (CYCN) (CIK 0001755237)
Date: April 22, 2019 · CIK: 0001755237 · Accession: 0001104659-19-022786
AI Filing Summary & Sentiment
File numbers found in text: 333-230944
Letter
Cyclerion Therapeutics, Inc.
301 Binney Street
Cambridge, MA 02142
April 22, 2019
VIA EDGAR AND E-MAIL
United States Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549-6010
Attention: Christine Westbrook
Re: Cylcerion Therapeutics, Inc. Registration Statement on Form S-1 (Registration File No. 333-230944)
Ladies and Gentlemen:
In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (Registration File No. 333-230944) (the “Registration Statement”) of Cyclerion Therapeutics, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern time, on April 23, 2019, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Bryan Keighery at (617) 341-7269.
[Remainder of page intentionally left blank]
Very truly yours,
Cyclerion Therapeutics, Inc.
Show Raw Text
CORRESP 1 filename1.htm Cyclerion Therapeutics, Inc. 301 Binney Street Cambridge, MA 02142 April 22, 2019 VIA EDGAR AND E-MAIL United States Securities and Exchange Commission Division of Corporation Finance 100 F Street, N.E. Washington, D.C. 20549-6010 Attention: Christine Westbrook Re: Cylcerion Therapeutics, Inc. Registration Statement on Form S-1 (Registration File No. 333-230944) Ladies and Gentlemen: In accordance with Rule 461 of Regulation C of the General Rules and Regulations under the Securities Act of 1933, as amended, we hereby request acceleration of the effective date of the Registration Statement on Form S-1 (Registration File No. 333-230944) (the “Registration Statement”) of Cyclerion Therapeutics, Inc. (the “Company”). We respectfully request that the Registration Statement become effective as of 4:00 p.m., Eastern time, on April 23, 2019, or as soon as practicable thereafter. Once the Registration Statement has been declared effective, please orally confirm that event with our counsel, Morgan, Lewis & Bockius LLP, by calling Bryan Keighery at (617) 341-7269. [Remainder of page intentionally left blank] Very truly yours, Cyclerion Therapeutics, Inc. By: /s/ Peter M. Hecht Peter M. Hecht, Chief Executive Officer CC: Larry Miller, Cyclerion Therapeutics, Inc. Laurie A. Cerveny, Morgan, Lewis & Bockius LLP Bryan S. Keighery, Morgan, Lewis & Bockius LLP [Cyclerion Therapeutics, Inc. — Signature Page to Request for Acceleration]